-
1.发明公开
公开(公告)号：EP4245309A1
公开(公告)日：2023-09-20
申请号：EP21891278.0
申请日：2021-11-16
申请人： Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人： WEISS, Gisela Adrienne , VAN LOO-BOUWMAN, Carolien Annika , SMIT, Gerrit , WANG, Wendan , SZETO, Ignatius Man-Yau , GU, Fangjie , LIU, Biao
IPC分类号： A61K35/745 , A61K31/702 , A61P31/04
摘要： The present disclosure provides a composition comprising Bifidobacterium lactis and human milk oligosaccharides (HMOs) and use thereof. The composition is capable of effectively enhancing resistance of an organism to Staphylococcus aureus infection, improving innate immunity of an organism, and/or anti-aging, and can be added to various health foods and healthcare foods.
-
2.发明公开
公开(公告)号：EP4252538A1
公开(公告)日：2023-10-04
申请号：EP21896062.3
申请日：2021-01-27
申请人： Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人： WANG, Wendan , SZETO, Ignatius Man-Yau , LIU, Biao
摘要： Disclosed is the use of a breast milk oligosaccharide in the preparation of a food product for improving intestinal microenvironment health. Improving intestinal microenvironment health comprises: in the intestinal system, using the breast milk oligosaccharide as prebiotics used by means of intestinal flora and producing gas, reducing pH to maintain intestinal microenvironment health, and/or reducing the production of branched-chain fatty acids such as isobutyric acid and/or isovaleric acid, and regulating the production of beneficial short-chain fatty acids such as formic acid, acetic acid, propionic acid and/or butyric acid in the intestinal system. The breast milk oligosaccharide is selected from one or more of fucosyl oligosaccharide, sialyl oligosaccharide or lactose-N-tetrasaccharide. The food product comprises an infant formula powder, a complementary food product, a nutritional supplement, and a nutritional supplement or food product for children of 3 years of age and over, teenagers and adults.
-
3.发明公开
公开(公告)号：EP4129302A1
公开(公告)日：2023-02-08
申请号：EP21780538.1
申请日：2021-04-06
申请人： Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人： WEISS, Gisela Adrienne , VAN LOO-BOUWMAN, Carolien Annika , SMIT, Gerrit , WANG, Wendan , SZETO, Ignatius Man-Yau , GU, Fangjie , LIU, Biao
IPC分类号： A61K31/702 , A61P31/00 , A61P1/00
摘要： A use of breast milk oligosaccharides in the preparation of a nutritional composition or drug; the nutritional composition or drug is used to prevent and/or treat diseases related to Staphylococcus aureus infection in an individual, to alleviate the discomfort associated with Staphylococcus aureus infection, to improve the resistance of an individual against Staphylococcus aureus infection, or to improve the innate immunity and/or resistance of an individual to aging. The breast milk oligosaccharides are selected from: 2'-fucosyllactose, 3-fucosyllactose, lactose-N-tetraose, 6'-sialyllactose, and any combination thereof, and a combination formed by 3'-sialyllactose and one or more among 2'-fucosyllactose, 3-fucosyllactose, lactose-N-tetraose, and 6'-sialyllactose.
-
公开(公告)号：EP4223137A1
公开(公告)日：2023-08-09
申请号：EP21873804.5
申请日：2021-02-22
申请人： Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Technology Research Institute Co., Ltd.
发明人： WESCOMBE, Philip Andrew , VASILJEVIC, Todor , ZHANG, Xingchang , WANG, Caiyun , SZETO, Ignatius Man-Yau , QU, Peng , LUO, Shubo , YUN, Zhanyou , FENG, Haotian
摘要： The present invention relates to the technical field of protein processing, and disclosed are a whey protein composition, and a preparation method therefor and the use thereof. The whey protein composition of the present invention comprises a whey protein and β-casein, wherein the mass ratio of the β-casein to the whey protein is not less than 4.5 : 95.5. The whey protein composition provided by the present invention is mainly composed of a novel whey protein ingredient, which has a slower digestion characteristic than other whey proteins currently on the market. The whey protein composition is a β-casein-riched whey protein concentrate to which micronized and complex natural polysaccharides can be added, and the function of delaying digestion to promote muscle synthesis and provide adequate nutrition can be achieved.
-
公开(公告)号：EP3812452A1
公开(公告)日：2021-04-28
申请号：EP19867197.6
申请日：2019-09-24
发明人： LIU, Wei-Hsien , ZHAO, Wen , HUNG, Wei-Lian , SUN, Ting , SZETO, Ignatius Man-Yau , FENG, Haotian , WESCOMBE, Philip Andrew , LI, Haoqiu
摘要： Provided are bifidobacterium lactis BL-99 capable of improving immunity and application thereof. The Bifidobacterium lactis BL-99 was deposited in the China General Microorganisms Collection Management Center (CGMCC) on April 26, 2018 with a deposit number of CGMCC No. 15650, has gastric acid resistance and intestinal fluid resistance, can significantly promote the growth of bifidobacteria and lactic acid bacteria, can significantly increase antibody-producing cells and half hemolysis value HC 50 , activate NK cell activity, can be used for preparing foods that improve immunity, and has the effects of preventing osteoporosis and improving blood calcium and/or phosphorus ions.
-
公开(公告)号：EP3822338A1
公开(公告)日：2021-05-19
申请号：EP19865158.0
申请日：2019-09-23
IPC分类号： C12N1/20 , A61K35/747 , A61P1/02 , A61P37/00 , C12R1/225
摘要： Provided are a Lactobacillus paracasei ET-22 strain, a composition containing the strain and the used thereof. The deposit number of the strain is CGMCC No. 15077.
-
7.发明公开
公开(公告)号：EP3811955A1
公开(公告)日：2021-04-28
申请号：EP19864086.4
申请日：2019-09-23
IPC分类号： A61K35/747 , C12N1/20 , A61P1/00
摘要： Provided is a novel application of Lactobacillus paracasei K56 capable of regulating the balance of gastrointestinal flora. The Lactobacillus paracasei (Lactobacillus paracasei subsp.paracasei) has an accession number of DSM27447. A single strain of the bacteria strain has the ability to significantly promote the growth of intestinal bifidobacteria and lactic acid bacteria, inhibit Desulfovibrio and/or Enterobacter in the intestine, inhibit Helicobacter pylori and/or Escherichia-Shigella, and to tolerate a simulated in vitro gastrointestinal fluid stress environment. Rat experiments show that the bacteria strain has no oral acute toxicity, no antibiotic resistance, and is safe for food processing.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.019 秒)
